Clinica Baviera Stock Current Valuation
| CBAV Stock | EUR 33.70 0.30 0.90% |
Valuation analysis of Clinica Baviera helps investors to measure Clinica Baviera's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Clinica Baviera's price fluctuation is very steady at this time. Calculation of the real value of Clinica Baviera is based on 3 months time horizon. Increasing Clinica Baviera's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Clinica Baviera is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clinica Stock. However, Clinica Baviera's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 33.7 | Real 28.9 | Hype 33.7 | Naive 34.03 |
The real value of Clinica Stock, also known as its intrinsic value, is the underlying worth of Clinica Baviera Company, which is reflected in its stock price. It is based on Clinica Baviera's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Clinica Baviera's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Clinica Baviera helps investors to forecast how Clinica stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clinica Baviera more accurately as focusing exclusively on Clinica Baviera's fundamentals will not take into account other important factors: Clinica Baviera Company Current Valuation Analysis
Clinica Baviera's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clinica Baviera Current Valuation | 301.63 M |
Most of Clinica Baviera's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clinica Baviera is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Clinica Baviera has a Current Valuation of 301.63 M. This is 97.9% lower than that of the Health Care Providers & Services sector and 96.13% lower than that of the Health Care industry. The current valuation for all Spain stocks is 98.19% higher than that of the company.
Clinica Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clinica Baviera's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clinica Baviera could also be used in its relative valuation, which is a method of valuing Clinica Baviera by comparing valuation metrics of similar companies.Clinica Baviera is currently under evaluation in current valuation category among its peers.
Clinica Fundamentals
| Return On Equity | 0.47 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 301.63 M | |||
| Shares Outstanding | 16.3 M | |||
| Shares Owned By Insiders | 91.61 % | |||
| Shares Owned By Institutions | 6.79 % | |||
| Price To Earning | 20.23 X | |||
| Price To Book | 4.33 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 172.73 M | |||
| Gross Profit | 89.2 M | |||
| EBITDA | 52.91 M | |||
| Net Income | 27.39 M | |||
| Cash And Equivalents | 10.79 M | |||
| Cash Per Share | 0.66 X | |||
| Total Debt | 6.52 M | |||
| Debt To Equity | 154.20 % | |||
| Current Ratio | 0.91 X | |||
| Book Value Per Share | 4.27 X | |||
| Cash Flow From Operations | 46.86 M | |||
| Earnings Per Share | 1.82 X | |||
| Target Price | 24.3 | |||
| Number Of Employees | 722 | |||
| Beta | 0.51 | |||
| Market Capitalization | 308.14 M | |||
| Total Asset | 133.81 M | |||
| Z Score | 29.2 | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 4.03 % | |||
| Net Asset | 133.81 M | |||
| Last Dividend Paid | 1.03 |
About Clinica Baviera Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clinica Baviera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clinica Baviera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clinica Baviera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Clinica Stock
Clinica Baviera financial ratios help investors to determine whether Clinica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clinica with respect to the benefits of owning Clinica Baviera security.